Trials / Terminated
TerminatedNCT01293981
Radiographic and Clinical Outcomes of PureGen in Posterior Lumbar (PLIF) and Transforaminal Interbody Fusion (TLIF)
Radiographic and Clinical Outcomes of PureGen Osteoprogenitor Cell Allograft in Posterior Lumbar and Transforaminal Interbody Fusion Procedures
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 6 (actual)
- Sponsor
- Alphatec Spine, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety and efficacy of PureGen Osteoprogenitor Cell Allograft in patients undergoing Posterior Lumbar or Transforaminal Interbody Fusion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | PureGen Osteoprogenitor Cell Allograft | PureGen Osteoprogenitor Cell Allograft. |
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2012-01-01
- First posted
- 2011-02-11
- Last updated
- 2016-01-20
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01293981. Inclusion in this directory is not an endorsement.